Industry Conference

An Australian firm is tackling a growing allergy risk in medical implants. Their work on the α-Gal epitope could be key to the future of tissue engineering.

As leaders of Prestige Consumer Healthcare prepare for a key investor conference, all eyes are on their strategy for leveraging iconic brands in a complex market.

With a key conference appearance, OPKO Health aims to translate its deep R&D pipeline into market confidence. Will investors buy into its long-term vision?

As AI-driven manipulation becomes a top-tier threat, Cyabra is pitching investors on a new asset class: digital trust. But can technology alone win the war?

As Chemed preps its investor pitch, its hospice arm soars while its plumbing giant faces a digital reckoning. Will a potential divestiture be the answer?

Newly restructured Niki BioSolutions faces Wall Street at a key conference, pitching its brain health innovations while battling steep losses and investor doubt.

Dubai's new Future Finance Week isn't just another conference. It's a calculated move to rewire global capital flows and cement its role as a top financial power.

Crypto exchange WEEX is blurring the lines between digital and traditional assets, betting on AI and a unified platform to redefine the future of trading.

As Neurogene prepares for a key investor conference, all eyes are on its lead candidate for Rett syndrome. The company bets its proprietary EXACT™ technology can solve a critical gene therapy challenge, holding immense promise for patients and investors alike.

A look at how a free virtual event is a calculated investment in building a resilient, global talent pipeline, blurring the lines between goodwill and corporate strategy.

Beyond the music, BIGBANG's 20th anniversary concert reveals a complex interplay of K-pop's enduring power, Hong Kong's economic ambitions, and TME's global strategy.

At IFA 2026, display giant BOE unveiled more than new screens; it revealed a sophisticated strategy for European integration. Is this the future of tech globalization?

While we focus on breakthrough drugs, the real story is often in the logistics. GCCL’s expansion into Asia-Pacific highlights the critical, and lucrative, world of clinical trial support.

As Southeast Asia grapples with rampant energy theft and grid strain, a Silicon Valley firm’s AI platform signals a major shift from collecting data to creating value.

At recent tech expos, OSCAL unveiled a bold strategy for the Middle East, targeting both the rugged enterprise market and the growing demand for home energy.

As Crane NXT readies for a key investor conference, its leadership will detail a strategy where trust, traceability, and tech converge to redefine global supply chains.

As TerrAscend executives head to a key investor conference, their pitch is about more than sales figures. It's a strategic play for institutional capital.

With sales down and its dividend cut, The Campbell's Company's new leadership faces a critical test at the upcoming Barclays investor conference.

With record earnings and bold moves into life sciences and aerospace, Donaldson is redefining its future. CEO and CFO will soon reveal the next steps.

As El Pollo Loco prepares to meet investors, we analyze the strategy behind its growth narrative amid shifting consumer trends and a competitive landscape.